132 related articles for article (PubMed ID: 17074020)
1. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.
Konishi M; Iwasa M; Araki J; Kobayashi Y; Katsuki A; Sumida Y; Nakagawa N; Kojima Y; Watanabe S; Adachi Y; Kaito M
J Gastroenterol Hepatol; 2006 Dec; 21(12):1821-5. PubMed ID: 17074020
[TBL] [Abstract][Full Text] [Related]
2. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
[TBL] [Abstract][Full Text] [Related]
3. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
4. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease.
Grammatikos G; Mühle C; Ferreiros N; Schroeter S; Bogdanou D; Schwalm S; Hintereder G; Kornhuber J; Zeuzem S; Sarrazin C; Pfeilschifter J
Biochim Biophys Acta; 2014 Jul; 1841(7):1012-20. PubMed ID: 24769340
[TBL] [Abstract][Full Text] [Related]
5. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
Vecchiet J; Falasca K; Cacciatore P; Zingariello P; Dalessandro M; Marinopiccoli M; D'Amico E; Palazzi C; Petrarca C; Conti P; Pizzigallo E; Guagnano MT
Ann Clin Lab Sci; 2005; 35(4):415-22. PubMed ID: 16254258
[TBL] [Abstract][Full Text] [Related]
6. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
Jian Wu Y; Shu Chen L; Gui Qiang W
Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
[TBL] [Abstract][Full Text] [Related]
7. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
Lin CC; Yin MC
Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
9. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
[TBL] [Abstract][Full Text] [Related]
10. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
11. Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.
Guo CH; Chen PC; Ko WS
Int J Med Sci; 2013; 10(6):730-7. PubMed ID: 23630437
[TBL] [Abstract][Full Text] [Related]
12. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.
Yesilova Z; Yaman H; Oktenli C; Ozcan A; Uygun A; Cakir E; Sanisoglu SY; Erdil A; Ates Y; Aslan M; Musabak U; Erbil MK; Karaeren N; Dagalp K
Am J Gastroenterol; 2005 Apr; 100(4):850-5. PubMed ID: 15784031
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis.
Casoinic F; Sampelean D; Buzoianu AD; Hancu N; Baston D
Rom J Intern Med; 2016 Dec; 54(4):228-236. PubMed ID: 28002036
[TBL] [Abstract][Full Text] [Related]
14. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease.
Sariçam T; Kircali B; Köken T
Turk J Gastroenterol; 2005 Jun; 16(2):65-70. PubMed ID: 16252194
[TBL] [Abstract][Full Text] [Related]
15. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F
J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.
Yoshida Y; Imai Y; Sawai Y; Saito Y; Cao J; Fukuda K; Niki E
J Gastroenterol Hepatol; 2010 Jan; 25(1):107-15. PubMed ID: 19780883
[TBL] [Abstract][Full Text] [Related]
17. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
Montuschi P; Corradi M; Ciabattoni G; Nightingale J; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):216-20. PubMed ID: 10390403
[TBL] [Abstract][Full Text] [Related]
18. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
Soresi M; Tripi S; Franco V; Giannitrapani L; Alessandri A; Rappa F; Vuturo O; Montalto G
Liver Int; 2006 Nov; 26(9):1119-25. PubMed ID: 17032413
[TBL] [Abstract][Full Text] [Related]
19. [An association between plasma levels of 8-isoprostane and alcohol drinking habits in Japanese volunteers].
Kitano S; Hisatomi H; Hibi N; Kawano K; Harada S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Apr; 39(2):105-17. PubMed ID: 15160889
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel.
Dechakhamphu S; Pinlaor S; Sitthithaworn P; Nair J; Bartsch H; Yongvanit P
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):310-8. PubMed ID: 20056652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
